Lumos Diagnostics Secures Baltic Distribution Deal for FebriDx Test

Lumos Diagnostics has secured a new European distribution agreement with Interlux Group to roll out its FebriDx point-of-care test across the Baltic region. The agreement enables FebriDx to be distributed into primary care, urgent care, and outpatient settings in Lithuania, Estonia, and Latvia. This expansion comes as Lumos sharpens its commercial focus around FebriDx, particularly in the US and Europe. The company has secured full US Medicare reimbursement for FebriDx and has been working to improve sales efficiency and target high-value healthcare providers in the US.